Angela Fan: Persistent Unmet Needs in Polycythemia Vera
Angela Fan, Lead Health Economics and Outcomes Research in Oncology, shared a post on LinkedIn about a recent article by Aaron T Gerds et al., published in Journal of Blood Medicine, adding:
“Pleased to share that our US retrospective real-world evidence study, Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment, was recently published in the Journal of Blood Medicine.
This study adds important peer-reviewed real-world evidence highlighting the persistent unmet needs and disease burden among patients with polycythemia vera (PV) despite current standard-of-care treatment.
The findings demonstrate that many treated patients continue to experience challenges achieving adequate hematocrit control and remain at risk for thromboembolic events in routine clinical practice.
The study further highlights the substantial clinical and economic burden of thromboembolic events, providing additional insight into PV‘s ongoing impact on patients and the healthcare system.
Congratulations to all of the authors on this important publication, and special thanks to Dr. Aaron Gerds, for his collaboration and contributions to this work.”
Title: Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment: A Retrospective Claims Study
Authors: Aaron T Gerds, Qi Fan, Michelle Jerry, Alicia Cerretani, Anh Thu Tran, Luis Hernandez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 20:38Konstantinos Bistas: Reduced Circulating Tregs in Pediatric Chronic Neutropenia
-
Sep 17, 2026, 15:33Gopal Patidar: Honoured to Contribute to the ASFA 2026 Guidelines for Therapeutic Apheresis
-
Sep 17, 2026, 20:36Cosima C. Hoch: Developing a 3D Organotypic Co-Culture Model for Pleomorphic Adenoma
-
Sep 17, 2026, 20:19Riten Kumar: Boston Children’s Hospital Ranked No. 1 in Seven Pediatric Specialties
-
Sep 17, 2026, 20:17Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management